Innoviva Inc.

Innoviva Inc.
Stock Exchange NASDAQ Stock Market
EPS
$3.57
Market Cap
$1.46 B
Shares Outstanding
101.26 M
Public Float
66.46 M

Profile

Address
2000 Sierra Point Parkway
Brisbane California 94005
United States
Employees -
Website http://www.inva.com
Updated 07/08/2019
Innoviva, Inc. engages in the development, commercialization, and financial management of bio-pharmaceuticals. Its portfolio includes Relvar Breo Ellipta, which is a once-daily combination medicine consisting of a long-acting beta2 agonist, vilanterol, and an inhaled corticosteroid, fluticasone furoate; and Anoro Ellipta, a once-daily medicine combining a long-acting muscarinic antagonist, umeclidinium bromide, LABA, VI. The company was founded by P.

Financials

View All

Odysseas Demosthenes Kostas
Chairman
Mark Dipaolo
Director